{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T17:09:39Z","timestamp":1763572179273,"version":"3.37.3"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2012,5,16]],"date-time":"2012-05-16T00:00:00Z","timestamp":1337126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100001868","name":"Taiwan National Science Council","doi-asserted-by":"crossref","award":["99-2314-B-75-046"],"award-info":[{"award-number":["99-2314-B-75-046"]}],"id":[{"id":"10.13039\/501100001868","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004737","name":"National Health Research Institute","doi-asserted-by":"publisher","award":["PS95-01"],"award-info":[{"award-number":["PS95-01"]}],"id":[{"id":"10.13039\/501100004737","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background.<\/jats:title>\n                  <jats:p>All published reports concerning secondary cytoreductive surgery for relapsed ovarian cancer have essentially been observational studies. However, the validity of observational studies is usually threatened from confounding by indication. We sought to address this issue by using comparative effectiveness methods to adjust for confounding.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods.<\/jats:title>\n                  <jats:p>Using a prospectively collected administrative health care database in a single institution, we identified 1,124 patients diagnosed with recurrent epithelial, tubal, and peritoneal cancers between 1990 and 2009. Effectiveness of secondary cytoreductive surgery using the conventional Cox proportional hazard model, propensity score, and instrumental variable were compared. Sensitivity analyses for residual confounding were explored using an array approach.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results.<\/jats:title>\n                  <jats:p>Secondary cytoreductive surgery prolonged overall survival with a hazard ratio (95% confidence interval) of 0.76 (range 0.66\u20130.87), using the Cox proportional hazard model. Propensity score methods produced comparable results: 0.75 (range 0.64\u20130.86) by nearest matching, 0.73 (0.65\u20130.82) by quintile stratification, 0.71 (0.65\u20130.77) by weighting, and 0.72 (0.63\u20130.83) by covariate adjustment. The instrumental variable method also produced a comparable estimate: 0.75 (range 0.65\u20130.86). Sensitivity analyses revealed that the true treatment effects may approach the null hypothesis if the association between unmeasured confounders and disease outcome is high.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions.<\/jats:title>\n                  <jats:p>This comparative effectiveness study provides supportive evidence for previous reports that secondary cytoreductive surgery may increase overall survival for patients with recurrent epithelial, tubal, and peritoneal cancers.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1634\/theoncologist.2011-0373","type":"journal-article","created":{"date-parts":[[2012,5,17]],"date-time":"2012-05-17T13:45:35Z","timestamp":1337262335000},"page":"847-855","source":"Crossref","is-referenced-by-count":14,"title":["The Role of Secondary Cytoreductive Surgery in Patients with Recurrent Epithelial Ovarian, Tubal, and Peritoneal Cancers: A Comparative Effectiveness Analysis"],"prefix":"10.1093","volume":"17","author":[{"given":"Chi-Mu","family":"Chuang","sequence":"first","affiliation":[{"name":"a Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Taipei Veterans General Hospital, Taipei, Taiwan"},{"name":"c Community Health Research Center and Institute of Public Health, National Yang-Ming University, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiing-Jeng","family":"Chou","sequence":"additional","affiliation":[{"name":"c Community Health Research Center and Institute of Public Health, National Yang-Ming University, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Shyen","family":"Yen","sequence":"additional","affiliation":[{"name":"a Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Taipei Veterans General Hospital, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuan-Chong","family":"Chao","sequence":"additional","affiliation":[{"name":"a Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Taipei Veterans General Hospital, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nae-Fang","family":"Twu","sequence":"additional","affiliation":[{"name":"a Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Taipei Veterans General Hospital, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua-Hsi","family":"Wu","sequence":"additional","affiliation":[{"name":"a Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Taipei Veterans General Hospital, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuo-Chang","family":"Wen","sequence":"additional","affiliation":[{"name":"a Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Taipei Veterans General Hospital, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Jen","family":"Chen","sequence":"additional","affiliation":[{"name":"a Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Taipei Veterans General Hospital, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng-Hui","family":"Wang","sequence":"additional","affiliation":[{"name":"a Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Taipei Veterans General Hospital, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung-Ru","family":"Lai","sequence":"additional","affiliation":[{"name":"b Division of Pathology, Department of Obstetrics and Gynecology, Taipei Veterans General Hospital, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pesus","family":"Chou","sequence":"additional","affiliation":[{"name":"c Community Health Research Center and Institute of Public Health, National Yang-Ming University, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2012,5,16]]},"reference":[{"key":"2021122308221266300_B1","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","article-title":"Cancer statistics, 2010","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"2021122308221266300_B2","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.2002.20.5.1248","article-title":"Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A metaanalysis","volume":"20","author":"Bristow","year":"2002","journal-title":"J Clin Oncol"},{"key":"2021122308221266300_B3","first-page":"189","article-title":"Survival of patients following secondary cytoreductive surgery in ovarian cancer","volume":"61","author":"Berek","year":"1983","journal-title":"Obstet Gynecol"},{"key":"2021122308221266300_B4","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0140-6736(02)07683-3","article-title":"Generation of allocation sequences in randomised trials: Chance, not choice","volume":"359","author":"Schulz","year":"2002","journal-title":"Lancet"},{"volume-title":"Carboplatin and paclitaxel with or without bevacizumab after surgery in treating patients with recurrent ovarian epithelial cancer, primary peritoneal cavity cancer, or fallopian tube cancer","key":"2021122308221266300_B5"},{"volume-title":"Study comparing tumor debulking surgery versus chemotherapy alone in recurrent platinum-sensitive ovarian cancer (DESKTOP III)","key":"2021122308221266300_B6"},{"key":"2021122308221266300_B7","first-page":"434","article-title":"Secondary cytoreduction for ovarian cancer following cisplatin therapy","volume":"11","author":"Segna","year":"1993","journal-title":"Clin Oncol"},{"key":"2021122308221266300_B8","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/(SICI)1097-0142(20000101)88:1<144::AID-CNCR20>3.0.CO;2-X","article-title":"The role of secondary cytoreductive surgery in the treatment of patients with recurrent epithelial ovarian carcinoma","volume":"88","author":"Eisenkop","year":"2000","journal-title":"Cancer"},{"key":"2021122308221266300_B9","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1006\/gyno.2000.5992","article-title":"Complete salvage surgical cytoreduction improves further survival of patients with late recurrent ovarian cancer","volume":"79","author":"Gadducci","year":"2000","journal-title":"Gynecol Oncol"},{"key":"2021122308221266300_B10","first-page":"1008","article-title":"Secondary cytoreductive surgery for recurrent epithelial ovarian cancer","volume":"99","author":"Tay","year":"2002","journal-title":"Obstet Gynecol"},{"key":"2021122308221266300_B11","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/sj.bjc.6602466","article-title":"Secondary cytoreductive surgery for recurrent epithelial ovarian carcinoma: Proposal for patients selection","volume":"92","author":"Onda","year":"2005","journal-title":"Br J Cancer"},{"key":"2021122308221266300_B12","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1002\/cncr.21845","article-title":"Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma","volume":"106","author":"Chi","year":"2006","journal-title":"Cancer"},{"key":"2021122308221266300_B13","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/cncr.22447","article-title":"Secondary cytoreductive surgery for localized, recurrent epithelial ovarian cancer: Analysis of prognostic factors and survival outcome","volume":"109","author":"Salani","year":"2007","journal-title":"Cancer"},{"key":"2021122308221266300_B14","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1245\/s10434-009-0357-0","article-title":"Surgery for recurrent ovarian cancer: role of peritoneal carcinomatosis: Exploratory analysis of the DESKTOP I Trial about risk factors, surgical implications, and prognostic value of peritoneal carcinomatosis","volume":"16","author":"Harter","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"2021122308221266300_B15","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/jso.21652","article-title":"Role of secondary cytoreductive surgery in ovarian cancer relapse: Who will benefit? A systematic analysis of 240 consecutive patients","volume":"102","author":"Sehouli","year":"2010","journal-title":"J Surg Oncol"},{"key":"2021122308221266300_B16","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ejso.2010.04.012","article-title":"Perioperative morbidity and outcome of secondary cytoreduction for recurrent epithelial ovarian cancer","volume":"36","author":"Woelber","year":"2010","journal-title":"Eur J Surg Oncol"},{"key":"2021122308221266300_B17","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/IGC.0b013e3182098002","article-title":"Potential survival benefit of secondary cytoreductive surgery for recurrent epithelial ovarian, tubal, and peritoneal cancers","volume":"21","author":"Goto","year":"2011","journal-title":"Int J Gynecol Cancer"},{"volume-title":"Research on the Comparative Effectiveness of Medical Treatments: Issues and Options for an Expanded Federal Role. Pub. No. 2975","year":"2007","author":"Congressional Budget Office","key":"2021122308221266300_B18"},{"key":"2021122308221266300_B19","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies","volume":"61","author":"Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"2021122308221266300_B20","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1532-5415.1999.tb01603.x","article-title":"Assessment and control for confounding by indication in observational studies","volume":"47","author":"Psaty","year":"1999","journal-title":"J Am Geriatr Soc"},{"key":"2021122308221266300_B21","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jclinepi.2005.07.004","article-title":"A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods","volume":"59","author":"Sturmer","year":"2006","journal-title":"J Clin Epidemiol"},{"key":"2021122308221266300_B22","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1093\/ije\/29.4.722","article-title":"An introduction to instrumental variables for epidemiologists","volume":"29","author":"Greenland","year":"2000","journal-title":"Int J Epidemiol"},{"key":"2021122308221266300_B23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/sim.1597","article-title":"Regression models for relative survival","volume":"23","author":"Dickman","year":"2004","journal-title":"Stat Med"},{"key":"2021122308221266300_B24","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/aje\/kwi106","article-title":"Analytic strategies to adjust confounding using exposure propensity scores and disease risk scores: Nonsteroidal anti-inflammatory drugs and short-term mortality in the elderly","volume":"161","author":"Sturmer","year":"2005","journal-title":"Am J Epidemiol"},{"volume-title":"Propensity Score Analysis: Statistical Methods and Applications","year":"2010","author":"Guo","key":"2021122308221266300_B25"},{"key":"2021122308221266300_B26","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1080\/01621459.1984.10478078","article-title":"Reducing bias in observational studies using subclassifcation on the propensity score","volume":"79","author":"Rosenbaum","year":"1984","journal-title":"J Am Stat Assoc"},{"key":"2021122308221266300_B27","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/pds.969","article-title":"Principles for modeling propensity scores in medical research: A systematic literature review","volume":"13","author":"Weitzen","year":"2004","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2021122308221266300_B28","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1002\/sim.2580","article-title":"A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: A Monte Carlo study","volume":"26","author":"Austin","year":"2007","journal-title":"Stat Med"},{"key":"2021122308221266300_B29","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/00001648-200009000-00011","article-title":"Marginal structural models and causal inference in epidemiology","volume":"11","author":"Robins","year":"2000","journal-title":"Epidemiology"},{"key":"2021122308221266300_B30","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/01.ede.0000193606.58671.c5","article-title":"Evaluating short-term drug effects using a physician-specific prescribing preference as an instrumental variable","volume":"17","author":"Brookhart","year":"2006","journal-title":"Epidemiology"},{"key":"2021122308221266300_B31","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/aje\/kwn299","article-title":"Instrumental variable analysis for estimation of treatment effects with dichotomous outcomes","volume":"169","author":"Rassen","year":"2009","journal-title":"Am J Epidemiol"},{"key":"2021122308221266300_B32","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1017\/CBO9780511614491.006","volume-title":"Identification and Inference for Econometric Models: Essays in Honor of Thomas Rothenberg","author":"Stock","year":"2005"},{"key":"2021122308221266300_B33","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/pds.1200","article-title":"Sensitivity analysis an external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics","volume":"15","author":"Schneeweiss","year":"2006","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2021122308221266300_B34","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/EDE.0b013e318212640c","article-title":"Nonexperimental comparative effectiveness research using linked healthcare databases","volume":"22","author":"Sturmer","year":"2011","journal-title":"Epidemiology"},{"key":"2021122308221266300_B35","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0895-4356(96)00236-3","article-title":"A simulation study of the number of events per variable on logistic regression analysis","volume":"49","author":"Peduzzi","year":"1996","journal-title":"J Clin Epidemiol"},{"key":"2021122308221266300_B36","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/sim.4780030207","article-title":"Regression modeling strategies for improved prognostic prediction","volume":"3","author":"Harrell","year":"1984","journal-title":"Stat Med"},{"key":"2021122308221266300_B37","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s10742-009-0045-3","article-title":"An intuitive review of methods for observational studies of comparative effectiveness","volume":"9","author":"Pizer","year":"2009","journal-title":"Health Serv Outcomes Res Methodol"},{"key":"2021122308221266300_B38","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1177\/1740774506075549","article-title":"An introduction to causal modelling in clinical trials","volume":"4","author":"Bellamy","year":"2007","journal-title":"Clin Trials"},{"key":"2021122308221266300_B39","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1093\/jnci\/djm127","article-title":"Cancer mortality in the United Status by education level and race","volume":"99","author":"Albano","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"2021122308221266300_B40","doi-asserted-by":"crossref","first-page":"947","DOI":"10.2165\/11591740-000000000-00000","article-title":"Molecular targeted therapy in ovarian cancer: What is on the horizon","volume":"71","author":"Kalachand","year":"2011","journal-title":"Drugs"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1634\/theoncologist.2011-0373","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1634\/theoncologist.2011-0373","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/17\/6\/847\/41859331\/oncolo_17_6_847.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/17\/6\/847\/41859331\/oncolo_17_6_847.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T21:20:52Z","timestamp":1640294452000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/17\/6\/847\/6400950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,16]]},"references-count":40,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2012,5,16]]},"published-print":{"date-parts":[[2012,6,1]]}},"URL":"https:\/\/doi.org\/10.1634\/theoncologist.2011-0373","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"type":"print","value":"1083-7159"},{"type":"electronic","value":"1549-490X"}],"subject":[],"published-other":{"date-parts":[[2012,6,1]]},"published":{"date-parts":[[2012,5,16]]}}}